Código QR

Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys

Establishing how many people have been infected by SARS-CoV-2 remains an urgent priority for controlling the COVID-19 pandemic. Serological tests that identify past infection can be used to estimate cumulative incidence, but the relative accuracy and robustness of various sampling strategies have be...

Descrición completa

Gardado en:
Principais autores: Daniel B Larremore, Bailey K Fosdick, Kate M Bubar, Sam Zhang, Stephen M Kissler, C Jessica E Metcalf, Caroline O Buckee, Yonatan H Grad
Formato: Artigo
Idioma:Inglês
Publicado: eLife Sciences Publications Ltd 2021-03-01
Series:eLife
Assuntos:
SARS-CoV-2
COVID-19
antibody
serology
modeling
uncertainty
Acceso en liña:https://elifesciences.org/articles/64206
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares